AMWL Stock Recent News

American Well's revenue growth and cost control are strong, but the short DHA contract extension raises concerns about long-term stability and reliability of key revenue streams. Amwell's shift to higher-margin software revenue is promising, but guidance was revised downward due to contract uncertainties and program exclusions. Cost reductions have improved EBITDA and cash flow outlook, but excessive cuts risk undermining R&D, marketing, and future growth potential.

BOSTON, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Amwell ®  (NYSE: AMWL), a leading technology-enabled care platform provider, announces that on August 8, Amwell made grants of RSUs covering an aggregate of 76,198 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees' employment with Amwell.

American Well (AMWL 21.02%), a major telehealth solutions provider, reported second-quarter 2025 results on August 5, 2025. The standout detail: GAAP revenue of $70.9 million in Q2 2025 outpaced analyst expectations by more than $7.4 million, alongside a record gross margin of 56.1% in Q2 2025.

Although the revenue and EPS for American Well (AMWL) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

American Well Corporation (NYSE:AMWL ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants Ido Schoenberg - Chairman & CEO Mark J. Hirschhorn - Executive VP, COO & CFO Sue Dooley - Head of Investor Relations Conference Call Participants Eric R.

American Well Corporation (AMWL) came out with a quarterly loss of $1.24 per share versus the Zacks Consensus Estimate of a loss of $1.84. This compares to a loss of $3.36 per share a year ago.

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the second quarter ended June 30. The company's second quarter earnings report may be viewed at investors.amwell.com.

BOSTON, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Amwell®  (NYSE: AMWL), a leading technology-enabled care platform provider, announced that as part of a Leidos-led partnership, it has been awarded an extension of its next-generation Digital First contract to power the digital transformation of the Military Health System (MHS), which serves approximately 9.6 million beneficiaries. Under the contract extension, Amwell will continue to provide its comprehensive technology-enabled care platform to power virtual care delivered by MHS providers.

American Well (AMWL) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

BOSTON, July 22, 2025 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, will report second quarter 2025 operating results after stock market trading hours on Tuesday, Aug. 5. Following the distribution of the earnings alert via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m.